Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sawai Group Holdings CoSWGHF 53 Cash-to-Debt is 0.22 as of Jun. 2026, which is 51% below its 10-year median of 0.45. GuruFocus rates SWGHF with a GF Score™ of 53/100 and a GF Value™ of $16.33. The stock has 4 warning signs investors should review. Among 950 Drug Manufacturers companies, Sawai Group Holdings Co ranks worse than 75.47% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Sawai Group Holdings Co's cash to debt ratio for the quarter that ended in Jun. 2026 was 0.22.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Sawai Group Holdings Cocouldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.
The historical rank and industry rank for Sawai Group Holdings Co's Cash-to-Debt or its related term are showing as below:
SWGHF'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.22 Med: 0.45 Max: 0.88
Current: 0.22
During the past 5 years, Sawai Group Holdings Co's highest Cash to Debt Ratio was 0.88. The lowest was 0.22. And the median was 0.45.
SWGHF's Cash-to-Debt is ranked worse than 75.47% of 950
companies
in the Drug Manufacturers industry
Industry Median: 0.98
vs SWGHF: 0.22
Sawai Group Holdings Co (OTCPK:SWGHF) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Sawai Group Holdings Co Cash-to-Debt Related Terms
Sawai Group Holdings Co Cash-to-Debt Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Sawai Group Holdings Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sawai Group Holdings Co Cash-to-Debt vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sawai Group Holdings Co's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Sawai Group Holdings Co's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sawai Group Holdings Co (SWGHF) has a Cash-to-Debt of 0.22 as of Jun. 2026. This is 51% below median its historical median of 0.45. Over the past decade, Sawai Group Holdings Co's Cash-to-Debt has ranged from 0.22 to 0.88. According to the industry distribution chart, Sawai Group Holdings Co ranks #717 out of 950 companies in the Drug Manufacturers industry, placing it in the top 75.5%.
Is Sawai Group Holdings Co's Cash-to-Debt too high?
Sawai Group Holdings Co's current Cash-to-Debt of 0.22 is 51% below median its 10-year median of 0.45. Over the past 10 years, this metric has ranged from a low of 0.22 to a high of 0.88. The Drug Manufacturers industry median Cash-to-Debt is 0.98. Sawai Group Holdings Co's value of 0.22 is 77.6% below this industry median. Based on the distribution chart, Sawai Group Holdings Co ranks #717 out of 950 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sawai Group Holdings Co has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Sawai Group Holdings Co's Cash-to-Debt compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sawai Group Holdings Co ranks #717 out of 950 companies for Cash-to-Debt. This places Sawai Group Holdings Co in the lower half of its industry. The industry median Cash-to-Debt is 0.98. Sawai Group Holdings Co's value of 0.22 is 77.6% below this benchmark. Historically, Sawai Group Holdings Co's own Cash-to-Debt has ranged from 0.22 to 0.88 over the past decade. While the company's 10-year median is 0.45 vs. the industry median of 0.98, Sawai Group Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Drug Manufacturers company?
The median Cash-to-Debt among Drug Manufacturers companies is 0.98, based on 950 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sawai Group Holdings Co's current Cash-to-Debt of 0.22 is 77.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Cash-to-Debt is 0.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sawai Group Holdings Co's current Cash-to-Debt is 0.22, which is 51% below median its own 10-year median of 0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sawai Group Holdings Co stock overvalued right now?
Sawai Group Holdings Co (SWGHF) has a current Cash-to-Debt of 0.22. The stock's GF Value™ is $16.33, compared to a current price of $11.52 — trading 29.5% below its estimated fair value. The current Cash-to-Debt is 0.22, which is 51% below median its 10-year median of 0.45 and 77.6% below the Drug Manufacturers industry median of 0.98. Sawai Group Holdings Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Sawai Group Holdings Co (SWGHF), the current Cash-to-Debt is 0.22 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sawai Group Holdings Co (SWGHF) Overvalued in 2026?
Based on GuruFocus' analysis, Sawai Group Holdings Co stock appears to be undervalued.
The current stock price of $11.52 is trading 29.5% below its estimated GF Value™ of $16.33.
Key valuation signals for SWGHF:
Cash-to-Debt: 0.22 (51% below median its 10-year median of 0.45)
GF Value™: $16.33 vs. price of $11.52 (29.5% below fair value)
Industry Position: 77.6% below the Drug Manufacturers median (#717 of 950)
No single metric tells the full story. See the SWGHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sawai Group Holdings Co Ltd is engaged in providing management support or guidance to domestic and foreign companies engaged in businesses related to medical and healthcare services, such as the manufacture and sale of pharmaceutical products and medical equipment, as well as various businesses incidental or related to the same.
53GF Score
Get the complete analysis for SWGHF
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SWGHF has been successfully added to your 
